NCT06851091 Investigation of the Relationship Between Central Sensitization and Balance in Fibromyalgia
| NCT ID | NCT06851091 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
| Condition | Fibromyalgia Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-02-18 |
| Primary Completion | 2025-09-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2025-02-18 with a primary completion date of 2025-09-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to investigate the relationship between central sensitization parameters and changes in static and dynamic balance in patients with fibromyalgia. The main questions it aims to answer are: * Do central sensitization parameters differ in patients with fibromyalgia compared to healthy individuals? * How is balance performance in these individuals compared to healthy controls? * Do central sensitization parameters affect static and dynamic balance in patients with fibromyalgia? * Do central sensitization parameters lead to quantitative changes in balance in patients with fibromyalgia?
Eligibility Criteria
Inclusion Criteria: * Diagnosis of FMS according to the ACR 2016 diagnostic criteria * Being between the ages of 18 and 65 * Being literate * Providing informed consent by signing the voluntary consent form Exclusion Criteria: * Being under 18 years old or over 65 years old * Presence of vestibular disorders * Having undergone spinal and/or extremity surgery (such as for back/hip/knee/foot) within the last 6 months * History of lower extremity amputation * Presence of spinal deformities * Peripheral arterial disease * Vitamin B12 deficiency * Any neurological disorder (e.g., stroke, traumatic brain injury, multiple sclerosis, Parkinson's disease, central nervous system malignancies, etc.) * Severe cardiopulmonary insufficiency (stage 3-4) * Uncontrolled systemic diseases such as hypertension and diabetes * Presence of systemic inflammatory diseases, malignancies, or active infections * Pregnancy
Contact & Investigator
Emre Ata, Asst. Prof.
STUDY DIRECTOR
Health Sciences University Sultan 2.Abdülhamid Han Training and Research Hospital
Frequently Asked Questions
Who can join the NCT06851091 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Fibromyalgia Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06851091 currently recruiting?
Yes, NCT06851091 is actively recruiting participants. Contact the research team at melikeunsal463@gmail.com for enrollment information.
Where is the NCT06851091 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06851091 clinical trial?
NCT06851091 is sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. The principal investigator is Emre Ata, Asst. Prof. at Health Sciences University Sultan 2.Abdülhamid Han Training and Research Hospital. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.